Maternal serum triple analyte screening and adverse pregnancy outcome

Fetal Diagnosis and Therapy

Volumn 11, Issue 4, 1996, Pages 249-253

  Milunsky, Aubrey ^a   Nebiolo, Linda ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Maternal serum screening; Pregnancy outcome

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; LOW BIRTH WEIGHT; MATERNAL SERUM; NEURAL TUBE DEFECT; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

EID: 0029938457     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264310     Document Type: Article

References (16)

1. Milunsky A: The use of biochemical markers in maternal screening for chromosomal defects: in Milunsky A (ed): Genetic Disorders of the Fetus: Diagnosis, Prevention and Treatment, ed 3, Baltimore, Johns Hopkins University Press, 1992, pp 565-592.
2. Milunsky A, Jick SS, Bruell CL, MacLaughlin DS, Tsung Y-K, Jick H, Rothman KJ, Willett W: Predictive values, relative risks, and overall benefitsof high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: New epidemiologic data, Am J Obstet Gynecol 1989:161:291-297.
3. Wald N, Cuckle H, Stirrat GM, Bennett MJ, Turnbull AC: Maternal serum alpha-fetoprotein and low birth weight, Lancet 1977;2:268-270.
4. Burton BK, Dillard RG: Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein, Pediatrics 1986:77:582-586.
5. Waller DK, Lustig I.S, Cunningham GC, Golbus MS, Hook EB: Second trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death, N Engl J Med 1991;325:6-10.
6. Crosignani PG: Correlation of human chorionic somatomammotropin with fetal nutrition; in Josimo-vich JB (ed): Lactogenic Hormones, Fetal Nutrition and Lactation, New York, Wiley, 1973, pp 203-220.
7. Bogart MH, Pandian MR, Jones W: Abnormal maternal scrum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenat Diagn 1987:7: 623-630.
8. Kosasa TS: Measurements of hCG: in Goldstein DP, Berkowitz RS (eds): Gestational Trophoblastic Neoplasms: Clinical Principles of Diagnosis and Management, vol 14, Philadelphia, Saunders, 1982, p 64.
9. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M: The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications, Obstet Gynecol 1991:80:83-86.
10. Wald NJ, Cucklc HS, Dcnscm JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA: Maternal scrum screening for Down's syndrome in early pregnancy, Br Med J 1988; 425:883-887.
11. Milunsky A, Jick H, Jick SS, Bruell C, MacLaughlin DS, Rothman KJ, Willett W: Multivitamin/folic acid supplementation in the earliest weeks of pregnancy reduces the prevalence of neural tube defects, JAMA 1989:262:2847-2852
12. Lieppman RE, Williams MA, Cheng EY, Resta R, Zinghcim R, Hickok DE, Luthy DA: An association between elevated levels of human chorionic gonadotropin in the midtri-mcstcr and adverse pregnancy outcome, Am J Obstet Gynecol 1993; 168:1852-1857.
13. Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M: The association between unexplained second-trimester maternal scrum hCG elevation and pregnancy complications, Obstet Gynecol 1992:80:83-86.
14. Fox H: Effect of hypoxia on tropho-blast in organ culture: A morphologic and autoradiographic study, Am J Obstet Gynecol 1970; 107: 1058-1064.
15. Milunsky A, Nebiolo L: Maternal serum triple analyte screening and adverse pregnancy outcome, Am J Hum Genet 1995;57:A1653.
16. Pergament E, Stein AK, Fiddler M, Cho NH, Kupfermine MJ: Adverse pregnancy outcome after a false-positive screen for Down's syndrome using multiple markers, Obstet Gynecol 1995:86:255-258.